master_crab

I assume RH and others probably knew at the same time as Linux. I’d lay more blame with them on the lack of movement.

For example, the huggingface hack is absolutely OpenAIs responsibility and they should be sued to the hilt. But if someone else uses a self or third party hosted anthropic model, they can escape liability (mostly?)

Same as with the argument over trucks, knives, and any other dual use item is used as weapons. you don’t blame the manufacturer.

(I am merely pontificating here. The law and precedent is nowhere near caught up on this)

I’d reserve judgement until i see them report more detailed financials and the big ratings agencies step in with assessment.

(edit: /s but not about making the government some money off this corruption)

The concern is real and very much deserves the opprobrium voters are showing.

(Edit: I am merely relaying what they said, not that I in anyway subscribe to it)

But everyone is now chasing the same opportunity (AI and its dependencies like hardware and power) that will drive prices higher in those sectors until supply responds (or demand disappears).

Also Nvidia isn’t really creating money. The 500B number is third party capital that already exists (BX, Apollo, etc).

Or even make! Many manufacturers use the same supplier for various parts. The lock actuator on my 2010 dodge pickup is also used in Fords.

More than likely Russia is ostracized to the point that other countries will treat it with active hostility.

And the most likely possibility is Putin is assassinated and the government overthrown due to internal opposition.

The same thing that would happen to America if Trump acts on his musings about tactically nuking Iran.

Both of these studies are observational and retrospective, meaning they can only show a correlation between GLP-1 use and reduced (or at least less severe) infections, not prove a direct cause-and-effect relationship. At the same time, these are the only latest pieces of evidence pointing to a genuine germ-busting benefit from GLP-1 drugs.

I wonder if the likelihood that people taking a GLP-1 are probably better off financially, have a health care provider willing to spend on the drugs (and therefore probably a better medical system) or a combination of these and other traits are the real reason there are fewer infections.

If it wasn’t economically feasible without VC/Nvidia money 3 years ago, how is it possibly economically feasible now at 10x prices for things like memory?